These stocks are the most active in today's session
By Mill Chart
Last update: Mar 28, 2024
Thursday's session: most active stocks
Today's most active stocks
| Ticker | Change | Comment |
|---|---|---|
| NKLA | 11.11% | Today, there has been significant activity in the market for NIKOLA CORP (NASDAQ:NKLA), with a total trading volume of 143.1M shares. NASDAQ:NKLA is advancing 11.11% today. |
| BDRX | 65.12% | The trading volume for BIODEXA PHARMACEUTICALS-ADR (NASDAQ:BDRX) has been quite high, with 84.72M shares exchanged. The market is experiencing a notable price surge, with a rise of 65.12% across the board. |
| GMDA | -38.18% | So far 79.33M shares of GAMIDA CELL LTD (NASDAQ:GMDA) have traded in today's session. With a decline of 38.18%, NASDAQ:GMDA is facing a downward movement in its share price today. |
| MARA | 2.45% | MARATHON DIGITAL HOLDINGS IN's (NASDAQ:MARA) traded a high volume of 74.06M shares. Shares are rising by 2.45% today, reflecting bullish market sentiment and upward price movement. |
| AKAN | -9.13% | Today, there has been significant activity in the market for AKANDA CORP (NASDAQ:AKAN), with a total trading volume of 69.5M shares. Investors observed a notable downturn in the market as NASDAQ:AKAN experienced a decline of 9.13%. |
| CISS | -5.76% | The trading session for C3IS INC (NASDAQ:CISS) has been active, with a total volume of 60.42M shares traded so far today. NASDAQ:CISS is declining 5.76% today. |
| TSLA | -1.91% | So far 59.25M shares of TESLA INC (NASDAQ:TSLA) have traded in today's session. Investors witnessed a notable decrease in share prices, with a loss of 1.91%. A press release (Low VIX? 3 High Beta Stocks To Boost Your Returns) was released yesterday. |
| PLTR | -5.79% | PALANTIR TECHNOLOGIES INC-A's (NYSE:PLTR) traded a high volume of 55.23M shares. The share price decreased by 5.79%. A press release (Palantir Technologies: Bearish Sentiment, Bullish Chart Signals) was released yesterday. |
| AKBA | -19.73% | The trading session for AKEBIA THERAPEUTICS INC (NASDAQ:AKBA) has been active, with a total volume of 54.98M shares traded so far today. The share price decreased by 19.73%. |
| IBIO | 23.21% | 47.9M shares of IBIO INC (NYSEARCA:IBIO) have been traded so far today. The share price increased by 23.21% today, indicating positive momentum in the market. |
To see the full list of most active stocks you can use our most active stocks screener.
IBIO INC
NYSEARCA:IBIO (5/1/2024, 7:04:00 PM)
After market: 1.86 +0.01 (+0.54%)1.85
+0.14 (+8.19%)
IBIO News
a month ago - InvestorPlace3 Healthcare Stocks Short Sellers Are Prescribing for TroubleThe healthcare industry is one of the most potent yet also one of the most competitive. This has short sellers out for blood.
a month ago - InvestorPlaceCanada Goose Layoffs 2024: What to Know About the Latest GOOS Job CutsCanada Goose layoffs are in the news Wednesday as the luxury apparel company prepares to cut 17% of its corporate employees.
a month ago - InvestorPlaceRENT Stock Alert: Rent the Runway Preps for a 1-for-20 Reverse Stock SplitRent the Runway stock is falling on Wednesday after the company announced a one-for-20 reverse split for its shares coming in April.
a month ago - InvestorPlaceWhy Is iBio (IBIO) Stock Up 125% Today?IBIO stock is soaring after the firm announced that it would launch a partnership based on AI and obesity treatments.
– Leading AI and precision biologics innovators to build a diverse set of novel best-in-class obesity treatments – – iBio to use its patented generative...
– Purchase price of $2.85 represents a premium of 148+% to last close –
2 months ago - Seeking AlphaiBio stock jumps on sale of preclinical PD-1 agonist antibody program (NYSE:IBIO)iBio shares surge as the biopharmaceutical company announces the sale of its preclinical PD-1 agonist antibody program to Otsuka Pharmaceutical, securing...
– Deal includes $1 million upfront and potential future milestone payments – – iBio’s proprietary therapeutic pipeline will now be comprised entirely of...
- VP of Platform Technologies, Matt Greving, to give podium presentation on enhancing bispecific T-cell engager discovery and development with machine...
4 months ago - Seeking AlphaiBio to extend maturity date of credit facility (NYSE:IBIO)iBio extends credit facility maturity date, providing more time for planned divestiture.
– Extends maturity date to March 29, 2024 – – Allows for more time to complete planned divestiture of legacy CDMO business - BRYAN, Texas and SAN...
5 months ago - InvestorPlacePiper Sandler Is Souring on Albemarle (ALB) StockAlbemarle stock is falling on Tuesday alongside a downgrade and price target reduction for ALB shares from a Piper Sandler analyst.
